434 related articles for article (PubMed ID: 23745468)
1. [Gout as a systemic disease: systemic manifestations and comorbidities of hyperuricaemia].
Glasnović M
Reumatizam; 2012; 59(2):119-32. PubMed ID: 23745468
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of gout.
Grassi W; De Angelis R
Reumatismo; 2012 Jan; 63(4):238-45. PubMed ID: 22303530
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis, diagnostics and therapy of gout].
Zurek M
Vnitr Lek; 2006; 52(7-8):736-41. PubMed ID: 16967617
[TBL] [Abstract][Full Text] [Related]
4. What do I need to know about gout?
Becker MA; Ruoff GE
J Fam Pract; 2010 Jun; 59(6 Suppl):S1-8. PubMed ID: 20544070
[TBL] [Abstract][Full Text] [Related]
5. Gout: joints and beyond, epidemiology, clinical features, treatment and co-morbidities.
Robinson PC; Horsburgh S
Maturitas; 2014 Aug; 78(4):245-51. PubMed ID: 24880206
[TBL] [Abstract][Full Text] [Related]
6. [Coexistence of systemic sclerosis and gout? Hyperuricemia in systemic sclerosis: case report and literature review].
Madej M; Morgiel E; Łuczak A; Kowalewska B; Wiland P
Ann Acad Med Stetin; 2012; 58(1):28-32; discussion 32. PubMed ID: 23547391
[TBL] [Abstract][Full Text] [Related]
7. Review of the ophthalmic manifestations of gout and uric acid crystal deposition.
Ao J; Goldblatt F; Casson RJ
Clin Exp Ophthalmol; 2017 Jan; 45(1):73-80. PubMed ID: 27010973
[TBL] [Abstract][Full Text] [Related]
8. Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?
Ruoff G; Edwards NL
Postgrad Med; 2016 Sep; 128(7):706-15. PubMed ID: 27558643
[TBL] [Abstract][Full Text] [Related]
9. Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 2: clinical features, diagnosis and differential diagnostics.
Schlee S; Bollheimer LC; Bertsch T; Sieber CC; Härle P
Z Gerontol Geriatr; 2018 Jul; 51(5):579-584. PubMed ID: 28233118
[TBL] [Abstract][Full Text] [Related]
10. Is there anything good in uric acid?
Alvarez-Lario B; Macarrón-Vicente J
QJM; 2011 Dec; 104(12):1015-24. PubMed ID: 21908382
[TBL] [Abstract][Full Text] [Related]
11. [Hyperuricemia and Gout].
Delbarba E; Terlizzi V; Dallera N; Izzi C; Scolari F
G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960024
[TBL] [Abstract][Full Text] [Related]
12. [Gout as a systemic disease. Manifestations, complications and comorbidities of hyperuricaemia].
Tausche AK; Manger B; Müller-Ladner U; Schmidt B
Z Rheumatol; 2012 Apr; 71(3):224-30. PubMed ID: 22415625
[TBL] [Abstract][Full Text] [Related]
13. [Gout and cardiovascular risk].
Němec P
Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and renal effects of hyperuricaemia and gout.
Viazzi F; Leoncini G; Pontremoli R
Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout).
Becker MA
Rheum Dis Clin North Am; 1988 Aug; 14(2):377-94. PubMed ID: 3051156
[TBL] [Abstract][Full Text] [Related]
16. Gout: an update.
Eggebeen AT
Am Fam Physician; 2007 Sep; 76(6):801-8. PubMed ID: 17910294
[TBL] [Abstract][Full Text] [Related]
17. [Tophaceous gout in plurimetabolic syndrome].
Iannello S; Cavaliere G; Ferro G; Giuffrì MV; Impellizzieri D; Incognito C; Lizzio G; Neri S; Rapisarda A; Belfiore F
Minerva Med; 1998; 89(11-12):419-37. PubMed ID: 10212666
[TBL] [Abstract][Full Text] [Related]
18. Hyperuricemia and gout.
German DC; Holmes EW
Med Clin North Am; 1986 Mar; 70(2):419-36. PubMed ID: 3512932
[TBL] [Abstract][Full Text] [Related]
19. Beyond Joints: a Review of Ocular Abnormalities in Gout and Hyperuricemia.
Sharon Y; Schlesinger N
Curr Rheumatol Rep; 2016 Jun; 18(6):37. PubMed ID: 27138165
[TBL] [Abstract][Full Text] [Related]
20. Treating to target: a strategy to cure gout.
Perez-Ruiz F
Rheumatology (Oxford); 2009 May; 48 Suppl 2():ii9-ii14. PubMed ID: 19447780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
